Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome

BACKGROUND AND AIMS: Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a valuable marker for identifying individuals at increased risk of metabolic dysfunction, liver-related complications, and cardiovascular disease. However, the association between MAFLD and testosterone...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chia-Chu, Huang, Shu-Pin, Lee, Yung-Chin, Lee, Cheng-Hsueh, Huang, Tsung-Yi, Geng, Jiun-Hung, Chang, Che-Wei, Lin, Chung-Yu, Juan, Yung-Shun, Wu, Wen-Jeng, Hsieh, Tusty-Jiuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579790/
https://www.ncbi.nlm.nih.gov/pubmed/37854195
http://dx.doi.org/10.3389/fendo.2023.1252774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579790/
https://www.ncbi.nlm.nih.gov/pubmed/37854195
http://dx.doi.org/10.3389/fendo.2023.1252774

Ejemplares similares